These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1928 related items for PubMed ID: 22932070

  • 1. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH, Fang Q, Zhang SY, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ, Yang M.
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [Abstract] [Full Text] [Related]

  • 2. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 3. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
    Harjai KJ, Sattur S, Orshaw P, Boura J.
    J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G, Saia F, Percoco G, Manari A, Santarelli A, Vignali L, Varani E, Benassi A, Sangiorgio P, Tarantino F, Magnavacchi P, De Palma R, Guastaroba P, Marzocchi A.
    Int J Cardiol; 2010 Apr 15; 140(2):154-60. PubMed ID: 19056134
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.
    JACC Cardiovasc Interv; 2013 Jun 15; 6(6):548-53. PubMed ID: 23683734
    [Abstract] [Full Text] [Related]

  • 6. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
    Violini R, Musto C, De Felice F, Nazzaro MS, Cifarelli A, Petitti T, Fiorilli R.
    J Am Coll Cardiol; 2010 Feb 23; 55(8):810-4. PubMed ID: 20170821
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, Frati G, Kedhi E, Smits PC, Kaiser C, Genereux P, Galatius S, Kirtane AJ, Stone GW.
    J Am Coll Cardiol; 2013 Aug 06; 62(6):496-504. PubMed ID: 23747778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of drug-eluting versus bare-metal stent implantation in ST-elevation myocardial infarction patients with renal insufficiency: results from the national registry in Korea.
    Kim KH, Koo BK, Min HS, Park SK, Kim CH, Park KW, Park BJ, Jeong MH, Cho MC, Lee SR, Chae SC, Seong IW, Choi DJ, Kim HS.
    Int J Cardiol; 2012 Jan 12; 154(1):71-7. PubMed ID: 20888053
    [Abstract] [Full Text] [Related]

  • 14. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH, Xie XJ, Fang Q, Zhang SY, Fang ZJ, Jiang XF, Xie HZ, Liu ZY, Shen ZJ.
    Zhonghua Yi Xue Za Zhi; 2011 Jan 25; 91(4):265-8. PubMed ID: 21418873
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS, Jibrin I, Abraham D, Merriman B, Wenz C, Bahr RD.
    Crit Pathw Cardiol; 2008 Dec 25; 7(4):232-8. PubMed ID: 19050419
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G, PRODIGY Investigators.
    JACC Cardiovasc Interv; 2014 Jan 25; 7(1):20-8. PubMed ID: 24332420
    [Abstract] [Full Text] [Related]

  • 18. Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.
    Kübler P, Jankowska EA, Ferenc M, Ponikowski P, Banasiak W, Reczuch K.
    Kardiol Pol; 2013 Jan 25; 71(1):25-31. PubMed ID: 23348530
    [Abstract] [Full Text] [Related]

  • 19. Clinical results of drug eluting stents compared to bare metal stents for patients with ST elevation acute myocardial infarction.
    Kornowski R, Vaknin-Assa H, Lev E, Ben-Dor I, Teplitsky I, Rechavia E, Brosh D, Fuchs S, Assali A.
    Acute Card Care; 2008 Jan 25; 10(3):167-72. PubMed ID: 18803074
    [Abstract] [Full Text] [Related]

  • 20. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E, Poh KK, Liang S, Lee RC, Low A, Teo SG, Tan HC.
    J Interv Cardiol; 2010 Apr 25; 23(2):101-8. PubMed ID: 20236214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.